Hepatitis A vaccine liposomal (Crucell)

甲型肝炎脂质体疫苗

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHepatitis A vaccine liposomal (Crucell)
Drug Alias NameIRIV-hepatitis A vaccineEpaxal JuniorHAVpur JuniorVirohep-A JuniorEpaxal +[7] 
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis A
Global Approved IndicationsHepatitis A
Approved Indications in ChinaN/A
Original Approved Country/TerritorySwitzerland
Original Approved Date1994/01/01
Country/TerritorySwitzerlandIsrael
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCrucell Holland Bv
Active IndicationsHepatitis A
Inactive IndicationsN/A

Other Information

ATC CodeJ07BC02
Related LinksWikipediaDrugBank